Pfizer Announces Submission of New Drug Application to the U.S. FDA for PAXLOVID
Pfizer Inc. announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for approval of PAXLOVID (nirmatrelvir tablets and ritonavir…
Read More...
Read More...
